Skip to the main content

Review article

CARDIORENAL SYNDROME TYPE 2 – LITERATURE REVIEW

DRAGAN NOVOSEL ; Osijek University Hospital Center, Department of Cardiology, Osijek, Croatia
NIKOLINA BAŠIĆ-JUKIĆ ; Zagreb University Hospital Center, Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Zagreb, Croatia
ZORIN MAKAROVIĆ ; Osijek University Hospital Center, Department of Cardiology, Osijek, Croatia
SANDRA MAKAROVIĆ ; Osijek University Hospital Center, Department of Cardiology, Osijek, Croatia
PETAR KES ; Zagreb University Hospital Center, Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Zagreb, Croatia


Full text: croatian pdf 95 Kb

page 161-164

downloads: 771

cite


Abstract

We performed literature search in the Pubmed database in July 2013. The key word used for search was cardiorenal syndrome type 2, limited to English language and humans. Over the last decade, a significant advance in the understanding of the cardiorenal syndrome has been achieved. However, precise pathogenesis remains to be clarified. Current treatment in postponing progression of cardiorenal syndrome type 2 is not efficient, although novel drugs like levosimendan and tezosentan seem promising. Future research is necessary to determine their role in the treatment of cardiorenal syndrome type 2.

Keywords

cardiorenal syndrome type 2; chronic renal failure; chronic heart failure

Hrčak ID:

126808

URI

https://hrcak.srce.hr/126808

Publication date:

14.9.2014.

Article data in other languages: croatian

Visits: 1.925 *